Become a Member

Become a Member

Welcome

SAM 2025

Register Event Website

27 - 29 March 2025 Bilbao, Spain

Thursday 27 Mar
Friday 28 Mar
Saturday 29 Mar

Onsite
Synoptic

Scientific

	Foyer	Room 0C	Room 0D


13:00
30
14:00			PL1 - News in contact dermatitis 2025 OPENING
30
15:00
30
16:00		SY7 - Joint Session SEAIC & SPAIC: Cracking the code of contact dermatitis: The importance of standard batteries	SY1 - What’s new in chronic urticaria management?
30
17:00
30
18:00		OAS1 - Oral Abstract Session 1 - Contact Dermatitis/Drug Reactions	WS1 - Differential diagnosis of cutaneous hypersensitivities
30
19:00
30	Networking reception
20:00
30
21:00

Scientific Industry

	Foyer	Room 0A	Room 0C	Room 0D


7:00
30		LL1 - Allergens in the European baseline series	LL2 - When to suspect contact dermatitis? Tips and tricks for the allergologist
8:00
30		SY5 - Practical management of cutaneous adverse drug reactions	OAS2 - Oral Abstract Session 2 - Atopic Dermatitis	SY2 - Chronic urticaria: Natural course, differential diagnosis and comorbidities
9:00
30
10:00
30				PL2 - Individual management of atopic dermatitis according to phenotypes and co-morbidities
11:00
30
12:00	POSTER DISCUSSION SESSION		Industry Session
30
13:00
30		WS2 - Urticaria/angioedema induced by drugs	OAS3 - Oral Abstract Session 3 - Urticaria/Angioedema	SY3 - Unsolved problems in allergic contact dermatitis
14:00
30
15:00
30		WS3 - Contact dermatitis and proteins	PC1 - Mast cell mediated angioedema without wheals: Is It urticaria or not?	SY4 - Multidisciplinary approach in systemic mastocytosis
16:00			FT1 - Flash Talk 1
30
17:00		Clinical case discussion in atopic dermatitis	FT2 - Flash Talk 2
30
18:00

	Room 0C


7:00
30
8:00
30
9:00
30
10:00
30
11:00
30
12:00	ISS1 - Transforming Healthcare: The Introduction of the First Omalizumab Biosimilar
30
13:00
30
14:00
30
15:00
30
16:00
30
17:00
30
18:00

Scientific

	Room 0C	Room 0D


7:00
30	LL3 - Patch tests in atopic dermatitis
8:00
30	WS4 - Recurrent angioedema: Is it mast cell or Bradykinin mediated?	SY6 - SAM 2025 JM session
9:00
30
10:00
30		PL3 - Achieving the goals of hereditary angioedema treatment (HAE)
11:00
30
12:00		CLOSING ADDRESS
30
13:00

Last updated
06.03.2025, 13:40